IMO a merger based on current share price would be bad. Goes back to the discussion that a potential BP can't justify to their shareholders giving CYDY value based on all the indications and CYDY can't accept a deal based on pennies on the dollar valuation. We need significant share price appreciation before any merger is complete or the current shareholders are only getting a small portion of leronlimabs value IMO.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.